Summary
Alvimopan, CAS 156053-89-3, (trade name Entereg) is a drug, which behaves as a peripherally acting μ-opioid receptor antagonist. It is currently only Food and Drug Administration approved for the treatment of postoperative ileus, which it received in May 2008.
According to APO Research, The global Alvimopan market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Alvimopan is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Alvimopan is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Alvimopan is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Alvimopan is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Alvimopan include Merck, Teva Pharmaceutical Industries Ltd and MSN Life Sciences Private Ltd, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Alvimopan, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Alvimopan, also provides the sales of main regions and countries. Of the upcoming market potential for Alvimopan, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Alvimopan sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Alvimopan market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Alvimopan sales, projected growth trends, production technology, application and end-user industry.
Alvimopan segment by Company
Merck
Teva Pharmaceutical Industries Ltd
MSN Life Sciences Private Ltd
Alvimopan segment by Type
Pharmaceutical Grade
Others
Alvimopan segment by Application
Pharmaceutical
Other
Alvimopan segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alvimopan market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Alvimopan and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alvimopan.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Alvimopan in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Alvimopan manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Alvimopan sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
1 Market Overview
1.1 Product Definition
1.2 Alvimopan Market by Type
1.2.1 Global Alvimopan Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Pharmaceutical Grade
1.2.3 Others
1.3 Alvimopan Market by Application
1.3.1 Global Alvimopan Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical
1.3.3 Other
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Alvimopan Market Dynamics
2.1 Alvimopan Industry Trends
2.2 Alvimopan Industry Drivers
2.3 Alvimopan Industry Opportunities and Challenges
2.4 Alvimopan Industry Restraints
3 Global Market Growth Prospects
3.1 Global Alvimopan Revenue Estimates and Forecasts (2019-2030)
3.2 Global Alvimopan Revenue by Region
3.2.1 Global Alvimopan Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Alvimopan Revenue by Region (2019-2024)
3.2.3 Global Alvimopan Revenue by Region (2025-2030)
3.2.4 Global Alvimopan Revenue Market Share by Region (2019-2030)
3.3 Global Alvimopan Sales Estimates and Forecasts 2019-2030
3.4 Global Alvimopan Sales by Region
3.4.1 Global Alvimopan Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Alvimopan Sales by Region (2019-2024)
3.4.3 Global Alvimopan Sales by Region (2025-2030)
3.4.4 Global Alvimopan Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 Market Competitive Landscape by Manufacturers
4.1 Global Alvimopan Revenue by Manufacturers
4.1.1 Global Alvimopan Revenue by Manufacturers (2019-2024)
4.1.2 Global Alvimopan Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Alvimopan Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Alvimopan Sales by Manufacturers
4.2.1 Global Alvimopan Sales by Manufacturers (2019-2024)
4.2.2 Global Alvimopan Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Alvimopan Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Alvimopan Sales Price by Manufacturers (2019-2024)
4.4 Global Alvimopan Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Alvimopan Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Alvimopan Manufacturers, Product Type & Application
4.7 Global Alvimopan Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Alvimopan Market CR5 and HHI
4.8.2 2023 Alvimopan Tier 1, Tier 2, and Tier 3
5 Alvimopan Market by Type
5.1 Global Alvimopan Revenue by Type
5.1.1 Global Alvimopan Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Alvimopan Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Alvimopan Revenue Market Share by Type (2019-2030)
5.2 Global Alvimopan Sales by Type
5.2.1 Global Alvimopan Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Alvimopan Sales by Type (2019-2030) & (KG)
5.2.3 Global Alvimopan Sales Market Share by Type (2019-2030)
5.3 Global Alvimopan Price by Type
6 Alvimopan Market by Application
6.1 Global Alvimopan Revenue by Application
6.1.1 Global Alvimopan Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Alvimopan Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Alvimopan Revenue Market Share by Application (2019-2030)
6.2 Global Alvimopan Sales by Application
6.2.1 Global Alvimopan Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Alvimopan Sales by Application (2019-2030) & (KG)
6.2.3 Global Alvimopan Sales Market Share by Application (2019-2030)
6.3 Global Alvimopan Price by Application
7 Company Profiles
7.1 Merck
7.1.1 Merck Comapny Information
7.1.2 Merck Business Overview
7.1.3 Merck Alvimopan Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Merck Alvimopan Product Portfolio
7.1.5 Merck Recent Developments
7.2 Teva Pharmaceutical Industries Ltd
7.2.1 Teva Pharmaceutical Industries Ltd Comapny Information
7.2.2 Teva Pharmaceutical Industries Ltd Business Overview
7.2.3 Teva Pharmaceutical Industries Ltd Alvimopan Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Teva Pharmaceutical Industries Ltd Alvimopan Product Portfolio
7.2.5 Teva Pharmaceutical Industries Ltd Recent Developments
7.3 MSN Life Sciences Private Ltd
7.3.1 MSN Life Sciences Private Ltd Comapny Information
7.3.2 MSN Life Sciences Private Ltd Business Overview
7.3.3 MSN Life Sciences Private Ltd Alvimopan Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 MSN Life Sciences Private Ltd Alvimopan Product Portfolio
7.3.5 MSN Life Sciences Private Ltd Recent Developments
8 North America
8.1 North America Alvimopan Market Size by Type
8.1.1 North America Alvimopan Revenue by Type (2019-2030)
8.1.2 North America Alvimopan Sales by Type (2019-2030)
8.1.3 North America Alvimopan Price by Type (2019-2030)
8.2 North America Alvimopan Market Size by Application
8.2.1 North America Alvimopan Revenue by Application (2019-2030)
8.2.2 North America Alvimopan Sales by Application (2019-2030)
8.2.3 North America Alvimopan Price by Application (2019-2030)
8.3 North America Alvimopan Market Size by Country
8.3.1 North America Alvimopan Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Alvimopan Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Alvimopan Price by Country (2019-2030)
8.3.4 United States
8.3.5 Canada
9 Europe
9.1 Europe Alvimopan Market Size by Type
9.1.1 Europe Alvimopan Revenue by Type (2019-2030)
9.1.2 Europe Alvimopan Sales by Type (2019-2030)
9.1.3 Europe Alvimopan Price by Type (2019-2030)
9.2 Europe Alvimopan Market Size by Application
9.2.1 Europe Alvimopan Revenue by Application (2019-2030)
9.2.2 Europe Alvimopan Sales by Application (2019-2030)
9.2.3 Europe Alvimopan Price by Application (2019-2030)
9.3 Europe Alvimopan Market Size by Country
9.3.1 Europe Alvimopan Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Alvimopan Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Alvimopan Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 China
10.1 China Alvimopan Market Size by Type
10.1.1 China Alvimopan Revenue by Type (2019-2030)
10.1.2 China Alvimopan Sales by Type (2019-2030)
10.1.3 China Alvimopan Price by Type (2019-2030)
10.2 China Alvimopan Market Size by Application
10.2.1 China Alvimopan Revenue by Application (2019-2030)
10.2.2 China Alvimopan Sales by Application (2019-2030)
10.2.3 China Alvimopan Price by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Alvimopan Market Size by Type
11.1.1 Asia Alvimopan Revenue by Type (2019-2030)
11.1.2 Asia Alvimopan Sales by Type (2019-2030)
11.1.3 Asia Alvimopan Price by Type (2019-2030)
11.2 Asia Alvimopan Market Size by Application
11.2.1 Asia Alvimopan Revenue by Application (2019-2030)
11.2.2 Asia Alvimopan Sales by Application (2019-2030)
11.2.3 Asia Alvimopan Price by Application (2019-2030)
11.3 Asia Alvimopan Market Size by Country
11.3.1 Asia Alvimopan Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Alvimopan Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Alvimopan Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 Middle East, Africa and Latin America
12.1 MEALA Alvimopan Market Size by Type
12.1.1 MEALA Alvimopan Revenue by Type (2019-2030)
12.1.2 MEALA Alvimopan Sales by Type (2019-2030)
12.1.3 MEALA Alvimopan Price by Type (2019-2030)
12.2 MEALA Alvimopan Market Size by Application
12.2.1 MEALA Alvimopan Revenue by Application (2019-2030)
12.2.2 MEALA Alvimopan Sales by Application (2019-2030)
12.2.3 MEALA Alvimopan Price by Application (2019-2030)
12.3 MEALA Alvimopan Market Size by Country
12.3.1 MEALA Alvimopan Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Alvimopan Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Alvimopan Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 Value Chain and Sales Channels Analysis
13.1 Alvimopan Value Chain Analysis
13.1.1 Alvimopan Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Alvimopan Production Mode & Process
13.2 Alvimopan Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Alvimopan Distributors
13.2.3 Alvimopan Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
List of Tables
Table 1. Global Alvimopan Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Pharmaceutical Grade Major Manufacturers
Table 3. Others Major Manufacturers
Table 4. Global Alvimopan Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 5. Pharmaceutical Major Manufacturers
Table 6. Other Major Manufacturers
Table 7. Alvimopan Industry Trends
Table 8. Alvimopan Industry Drivers
Table 9. Alvimopan Industry Opportunities and Challenges
Table 10. Alvimopan Industry Restraints
Table 11. Global Alvimopan Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 12. Global Alvimopan Revenue by Region (2019-2024) & (US$ Million)
Table 13. Global Alvimopan Revenue by Region (2025-2030) & (US$ Million)
Table 14. Global Alvimopan Revenue Market Share by Region (2019-2024)
Table 15. Global Alvimopan Revenue Market Share by Region (2025-2030)
Table 16. Global Alvimopan Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (KG)
Table 17. Global Alvimopan Sales by Region (2019-2024) & (KG)
Table 18. Global Alvimopan Sales by Region (2025-2030) & (KG)
Table 19. Global Alvimopan Sales Market Share by Region (2019-2024)
Table 20. Global Alvimopan Sales Market Share by Region (2025-2030)
Table 21. Global Alvimopan Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 22. Global Alvimopan Revenue Market Share by Manufacturers (2019-2024)
Table 23. Global Alvimopan Sales by Manufacturers (US$ Million) & (2019-2024)
Table 24. Global Alvimopan Sales Market Share by Manufacturers (2019-2024)
Table 25. Global Alvimopan Sales Price (US$/g) of Manufacturers (2019-2024)
Table 26. Global Alvimopan Key Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 27. Global Alvimopan Key Manufacturers Manufacturing Sites & Headquarters
Table 28. Global Alvimopan Manufacturers, Product Type & Application
Table 29. Global Alvimopan Manufacturers Commercialization Time
Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Alvimopan by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 32. Global Alvimopan Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 33. Global Alvimopan Revenue by Type (2019-2024) & (US$ Million)
Table 34. Global Alvimopan Revenue by Type (2025-2030) & (US$ Million)
Table 35. Global Alvimopan Revenue Market Share by Type (2019-2024)
Table 36. Global Alvimopan Revenue Market Share by Type (2025-2030)
Table 37. Global Alvimopan Sales by Type 2019 VS 2023 VS 2030 (KG)
Table 38. Global Alvimopan Sales by Type (2019-2024) & (KG)
Table 39. Global Alvimopan Sales by Type (2025-2030) & (KG)
Table 40. Global Alvimopan Sales Market Share by Type (2019-2024)
Table 41. Global Alvimopan Sales Market Share by Type (2025-2030)
Table 42. Global Alvimopan Price by Type (2019-2024) & (US$/g)
Table 43. Global Alvimopan Price by Type (2025-2030) & (US$/g)
Table 44. Global Alvimopan Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 45. Global Alvimopan Revenue by Application (2019-2024) & (US$ Million)
Table 46. Global Alvimopan Revenue by Application (2025-2030) & (US$ Million)
Table 47. Global Alvimopan Revenue Market Share by Application (2019-2024)
Table 48. Global Alvimopan Revenue Market Share by Application (2025-2030)
Table 49. Global Alvimopan Sales by Application 2019 VS 2023 VS 2030 (KG)
Table 50. Global Alvimopan Sales by Application (2019-2024) & (KG)
Table 51. Global Alvimopan Sales by Application (2025-2030) & (KG)
Table 52. Global Alvimopan Sales Market Share by Application (2019-2024)
Table 53. Global Alvimopan Sales Market Share by Application (2025-2030)
Table 54. Global Alvimopan Price by Application (2019-2024) & (US$/g)
Table 55. Global Alvimopan Price by Application (2025-2030) & (US$/g)
Table 56. Merck Company Information
Table 57. Merck Business Overview
Table 58. Merck Alvimopan Sales (KG), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
Table 59. Merck Alvimopan Product Portfolio
Table 60. Merck Recent Development
Table 61. Teva Pharmaceutical Industries Ltd Company Information
Table 62. Teva Pharmaceutical Industries Ltd Business Overview
Table 63. Teva Pharmaceutical Industries Ltd Alvimopan Sales (KG), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
Table 64. Teva Pharmaceutical Industries Ltd Alvimopan Product Portfolio
Table 65. Teva Pharmaceutical Industries Ltd Recent Development
Table 66. MSN Life Sciences Private Ltd Company Information
Table 67. MSN Life Sciences Private Ltd Business Overview
Table 68. MSN Life Sciences Private Ltd Alvimopan Sales (KG), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
Table 69. MSN Life Sciences Private Ltd Alvimopan Product Portfolio
Table 70. MSN Life Sciences Private Ltd Recent Development
Table 71. North America Alvimopan Revenue by Type (2019-2024) & (US$ Million)
Table 72. North America Alvimopan Revenue by Type (2025-2030) & (US$ Million)
Table 73. North America Alvimopan Sales by Type (2019-2024) & (KG)
Table 74. North America Alvimopan Sales by Type (2025-2030) & (KG)
Table 75. North America Alvimopan Sales Price by Type (2019-2024) & (US$/g)
Table 76. North America Alvimopan Sales Price by Type (2025-2030) & (US$/g)
Table 77. North America Alvimopan Revenue by Application (2019-2024) & (US$ Million)
Table 78. North America Alvimopan Revenue by Application (2025-2030) & (US$ Million)
Table 79. North America Alvimopan Sales by Application (2019-2024) & (KG)
Table 80. North America Alvimopan Sales by Application (2025-2030) & (KG)
Table 81. North America Alvimopan Sales Price by Application (2019-2024) & (US$/g)
Table 82. North America Alvimopan Sales Price by Application (2025-2030) & (US$/g)
Table 83. North America Alvimopan Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 84. North America Alvimopan Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 85. North America Alvimopan Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 86. North America Alvimopan Sales by Country (2019 VS 2023 VS 2030) & (KG)
Table 87. North America Alvimopan Sales by Country (2019-2024) & (KG)
Table 88. North America Alvimopan Sales by Country (2025-2030) & (KG)
Table 89. North America Alvimopan Sales Price by Country (2019-2024) & (US$/g)
Table 90. North America Alvimopan Sales Price by Country (2025-2030) & (US$/g)
Table 91. US Alvimopan Revenue (2019-2030) & (US$ Million)
Table 92. Canada Alvimopan Revenue (2019-2030) & (US$ Million)
Table 93. Europe Alvimopan Revenue by Type (2019-2024) & (US$ Million)
Table 94. Europe Alvimopan Revenue by Type (2025-2030) & (US$ Million)
Table 95. Europe Alvimopan Sales by Type (2019-2024) & (KG)
Table 96. Europe Alvimopan Sales by Type (2025-2030) & (KG)
Table 97. Europe Alvimopan Sales Price by Type (2019-2024) & (US$/g)
Table 98. Europe Alvimopan Sales Price by Type (2025-2030) & (US$/g)
Table 99. Europe Alvimopan Revenue by Application (2019-2024) & (US$ Million)
Table 100. Europe Alvimopan Revenue by Application (2025-2030) & (US$ Million)
Table 101. Europe Alvimopan Sales by Application (2019-2024) & (KG)
Table 102. Europe Alvimopan Sales by Application (2025-2030) & (KG)
Table 103. Europe Alvimopan Sales Price by Application (2019-2024) & (US$/g)
Table 104. Europe Alvimopan Sales Price by Application (2025-2030) & (US$/g)
Table 105. Europe Alvimopan Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 106. Europe Alvimopan Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 107. Europe Alvimopan Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 108. Europe Alvimopan Sales by Country (2019 VS 2023 VS 2030) & (KG)
Table 109. Europe Alvimopan Sales by Country (2019-2024) & (KG)
Table 110. Europe Alvimopan Sales by Country (2025-2030) & (KG)
Table 111. Europe Alvimopan Sales Price by Country (2019-2024) & (US$/g)
Table 112. Europe Alvimopan Sales Price by Country (2025-2030) & (US$/g)
Table 113. Germany Alvimopan Revenue (2019-2030) & (US$ Million)
Table 114. France Alvimopan Revenue (2019-2030) & (US$ Million)
Table 115. Alvimopan Revenue (2019-2030) & (US$ Million)
Table 116. Alvimopan Revenue (2019-2030) & (US$ Million)
Table 117. Alvimopan Revenue (2019-2030) & (US$ Million)
Table 118. China Alvimopan Revenue by Type (2019-2024) & (US$ Million)
Table 119. China Alvimopan Revenue by Type (2025-2030) & (US$ Million)
Table 120. China Alvimopan Sales by Type (2019-2024) & (KG)
Table 121. China Alvimopan Sales by Type (2025-2030) & (KG)
Table 122. China Alvimopan Sales Price by Type (2019-2024) & (US$/g)
Table 123. China Alvimopan Sales Price by Type (2025-2030) & (US$/g)
Table 124. China Alvimopan Revenue by Application (2019-2024) & (US$ Million)
Table 125. China Alvimopan Revenue by Application (2025-2030) & (US$ Million)
Table 126. China Alvimopan Sales by Application (2019-2024) & (KG)
Table 127. China Alvimopan Sales by Application (2025-2030) & (KG)
Table 128. China Alvimopan Sales Price by Application (2019-2024) & (US$/g)
Table 129. China Alvimopan Sales Price by Application (2025-2030) & (US$/g)
Table 130. Asia Alvimopan Revenue by Type (2019-2024) & (US$ Million)
Table 131. Asia Alvimopan Revenue by Type (2025-2030) & (US$ Million)
Table 132. Asia Alvimopan Sales by Type (2019-2024) & (KG)
Table 133. Asia Alvimopan Sales by Type (2025-2030) & (KG)
Table 134. Asia Alvimopan Sales Price by Type (2019-2024) & (US$/g)
Table 135. Asia Alvimopan Sales Price by Type (2025-2030) & (US$/g)
Table 136. Asia Alvimopan Revenue by Application (2019-2024) & (US$ Million)
Table 137. Asia Alvimopan Revenue by Application (2025-2030) & (US$ Million)
Table 138. Asia Alvimopan Sales by Application (2019-2024) & (KG)
Table 139. Asia Alvimopan Sales by Application (2025-2030) & (KG)
Table 140. Asia Alvimopan Sales Price by Application (2019-2024) & (US$/g)
Table 141. Asia Alvimopan Sales Price by Application (2025-2030) & (US$/g)
Table 142. Asia Alvimopan Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 143. Asia Alvimopan Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 144. Asia Alvimopan Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 145. Asia Alvimopan Sales by Country (2019 VS 2023 VS 2030) & (KG)
Table 146. Asia Alvimopan Sales by Country (2019-2024) & (KG)
Table 147. Asia Alvimopan Sales by Country (2025-2030) & (KG)
Table 148. Asia Alvimopan Sales Price by Country (2019-2024) & (US$/g)
Table 149. Asia Alvimopan Sales Price by Country (2025-2030) & (US$/g)
Table 150. Japan Alvimopan Revenue (2019-2030) & (US$ Million)
Table 151. South Korea Alvimopan Revenue (2019-2030) & (US$ Million)
Table 152. Alvimopan Revenue (2019-2030) & (US$ Million)
Table 153. Alvimopan Revenue (2019-2030) & (US$ Million)
Table 154. Alvimopan Revenue (2019-2030) & (US$ Million)
Table 155. Alvimopan Revenue (2019-2030) & (US$ Million)
Table 156. Alvimopan Revenue (2019-2030) & (US$ Million)
Table 157. Alvimopan Revenue (2019-2030) & (US$ Million)
Table 158. MEALA Alvimopan Revenue by Type (2019-2024) & (US$ Million)
Table 159. MEALA Alvimopan Revenue by Type (2025-2030) & (US$ Million)
Table 160. MEALA Alvimopan Sales by Type (2019-2024) & (KG)
Table 161. MEALA Alvimopan Sales by Type (2025-2030) & (KG)
Table 162. MEALA Alvimopan Sales Price by Type (2019-2024) & (US$/g)
Table 163. MEALA Alvimopan Sales Price by Type (2025-2030) & (US$/g)
Table 164. MEALA Alvimopan Revenue by Application (2019-2024) & (US$ Million)
Table 165. MEALA Alvimopan Revenue by Application (2025-2030) & (US$ Million)
Table 166. MEALA Alvimopan Sales by Application (2019-2024) & (KG)
Table 167. MEALA Alvimopan Sales by Application (2025-2030) & (KG)
Table 168. MEALA Alvimopan Sales Price by Application (2019-2024) & (US$/g)
Table 169. MEALA Alvimopan Sales Price by Application (2025-2030) & (US$/g)
Table 170. MEALA Alvimopan Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 171. MEALA Alvimopan Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 172. MEALA Alvimopan Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 173. MEALA Alvimopan Sales by Country (2019 VS 2023 VS 2030) & (KG)
Table 174. MEALA Alvimopan Sales by Country (2019-2024) & (KG)
Table 175. MEALA Alvimopan Sales by Country (2025-2030) & (KG)
Table 176. MEALA Alvimopan Sales Price by Country (2019-2024) & (US$/g)
Table 177. MEALA Alvimopan Sales Price by Country (2025-2030) & (US$/g)
Table 178. Mexico Alvimopan Revenue (2019-2030) & (US$ Million)
Table 179. Brazil Alvimopan Revenue (2019-2030) & (US$ Million)
Table 180. Israel Alvimopan Revenue (2019-2030) & (US$ Million)
Table 181. Argentina Alvimopan Revenue (2019-2030) & (US$ Million)
Table 182. Colombia Alvimopan Revenue (2019-2030) & (US$ Million)
Table 183. Turkey Alvimopan Revenue (2019-2030) & (US$ Million)
Table 184. Saudi Arabia Alvimopan Revenue (2019-2030) & (US$ Million)
Table 185. UAE Alvimopan Revenue (2019-2030) & (US$ Million)
Table 186. Key Raw Materials
Table 187. Raw Materials Key Suppliers
Table 188. Alvimopan Distributors List
Table 189. Alvimopan Customers List
Table 190. Research Programs/Design for This Report
Table 191. Authors List of This Report
Table 192. Secondary Sources
Table 193. Primary Sources
List of Figures
Figure 1. Alvimopan Product Picture
Figure 2. Global Alvimopan Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Alvimopan Market Size Share 2019 VS 2023 VS 2030
Figure 4. Pharmaceutical Grade Picture
Figure 5. Others Picture
Figure 6. Global Alvimopan Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Figure 7. Global Alvimopan Market Size Share 2019 VS 2023 VS 2030
Figure 8. Pharmaceutical Picture
Figure 9. Other Picture
Figure 10. Global Alvimopan Revenue (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Alvimopan Revenue (2019-2030) & (US$ Million)
Figure 12. Global Alvimopan Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 13. Global Alvimopan Revenue Market Share by Region: 2023 Versus 2030
Figure 14. Global Alvimopan Revenue Market Share by Region (2019-2030)
Figure 15. Global Alvimopan Sales (2019-2030) & (KG)
Figure 16. Global Alvimopan Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (KG)
Figure 17. Global Alvimopan Sales Market Share by Region (2019-2030)
Figure 18. US & Canada Alvimopan Sales YoY (2019-2030) & (KG)
Figure 19. Europe Alvimopan Sales YoY (2019-2030) & (KG)
Figure 20. China Alvimopan Sales YoY (2019-2030) & (KG)
Figure 21. Asia (Excluding China) Alvimopan Sales YoY (2019-2030) & (KG)
Figure 22. Middle East, Africa and Latin America (Excluding China) Alvimopan Sales YoY (2019-2030) & (KG)
Figure 23. Global Alvimopan Manufacturers Revenue Share Top 10 and Top 5 in 2023
Figure 24. Global Alvimopan Manufacturers Sales Share Top 10 and Top 5 in 2023
Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 26. Global Alvimopan Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 27. Global Alvimopan Revenue Market Share by Type 2019 VS 2023 VS 2030
Figure 28. Global Alvimopan Revenue Market Share by Type (2019-2030)
Figure 29. Global Alvimopan Sales by Type (2019 VS 2023 VS 2030) & (KG)
Figure 30. Global Alvimopan Sales Market Share by Type 2019 VS 2023 VS 2030
Figure 31. Global Alvimopan Sales Market Share by Type (2019-2030)
Figure 32. Global Alvimopan Revenue by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 33. Global Alvimopan Revenue Market Share by Application 2019 VS 2023 VS 2030
Figure 34. Global Alvimopan Revenue Market Share by Application (2019-2030)
Figure 35. Global Alvimopan Sales by Application (2019 VS 2023 VS 2030) & (KG)
Figure 36. Global Alvimopan Sales Market Share by Application 2019 VS 2023 VS 2030
Figure 37. Global Alvimopan Sales Market Share by Application (2019-2030)
Figure 38. North America Alvimopan Revenue Share by Type (2019-2030)
Figure 39. North America Alvimopan Sales Share by Type (2019-2030)
Figure 40. North America Alvimopan Revenue Share by Application (2019-2030)
Figure 41. North America Alvimopan Sales Share by Application (2019-2030)
Figure 42. North America Alvimopan Revenue Share by Country (2019-2030)
Figure 43. North America Alvimopan Sales Share by Country (2019-2030)
Figure 44. Europe Alvimopan Revenue Share by Type (2019-2030)
Figure 45. Europe Alvimopan Sales Share by Type (2019-2030)
Figure 46. Europe Alvimopan Revenue Share by Application (2019-2030)
Figure 47. Europe Alvimopan Sales Share by Application (2019-2030)
Figure 48. Europe Alvimopan Revenue Share by Country (2019-2030)
Figure 49. Europe Alvimopan Sales Share by Country (2019-2030)
Figure 50. China Alvimopan Revenue Share by Type (2019-2030)
Figure 51. China Alvimopan Sales Share by Type (2019-2030)
Figure 52. China Alvimopan Revenue Share by Application (2019-2030)
Figure 53. China Alvimopan Sales Share by Application (2019-2030)
Figure 54. Asia Alvimopan Revenue Share by Type (2019-2030)
Figure 55. Asia Alvimopan Sales Share by Type (2019-2030)
Figure 56. Asia Alvimopan Revenue Share by Application (2019-2030)
Figure 57. Asia Alvimopan Sales Share by Application (2019-2030)
Figure 58. Asia Alvimopan Revenue Share by Country (2019-2030)
Figure 59. Asia Alvimopan Sales Share by Country (2019-2030)
Figure 60. MEALA Alvimopan Revenue Share by Type (2019-2030)
Figure 61. MEALA Alvimopan Sales Share by Type (2019-2030)
Figure 62. MEALA Alvimopan Revenue Share by Application (2019-2030)
Figure 63. MEALA Alvimopan Sales Share by Application (2019-2030)
Figure 64. MEALA Alvimopan Revenue Share by Country (2019-2030)
Figure 65. MEALA Alvimopan Sales Share by Country (2019-2030)
Figure 66. Alvimopan Value Chain
Figure 67. Manufacturing Cost Structure
Figure 68. Alvimopan Production Mode & Process
Figure 69. Direct Comparison with Distribution Share
Figure 70. Distributors Profiles
Figure 71. Years Considered
Figure 72. Research Process
Figure 73. Key Executives Interviewed
